Free Trial

RxSight (RXST) SEC Filings & 10K Form

RxSight logo
$45.35 +0.54 (+1.21%)
(As of 11:20 AM ET)

Recent RxSight SEC Filings

DateFilerForm TypeView
11/18/2024
8:50 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:18 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:42 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:14 PM
Corley Jesse Anderson (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
RxSight (Subject)
Form SC 13G/A
11/12/2024
3:50 PM
RxSight (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:40 AM
Artisan Partners Limited Partnership (Filed by)
RxSight (Subject)
Form SC 13G/A
11/08/2024
3:00 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
RxSight (Subject)
Form SC 13G/A
11/05/2024
3:05 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
3:17 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
12:52 PM
RxSight (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
4:22 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:28 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
7:55 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:17 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
RxSight (Subject)
Form SC 13G/A
10/22/2024
3:16 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:23 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
3:16 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:23 AM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:17 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
5:00 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:19 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
7:05 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:14 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2024
3:09 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
5:48 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:41 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
4:57 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
7:15 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
6:12 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:54 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
2:29 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
06/17/2024
5:45 PM
Andrews Julie (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:17 PM
LINK WILLIAM J PHD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:20 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:23 PM
PALMISANO ROBERT J (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:11 PM
RxSight (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
RxSight (Filer)
Form SD
Specialized Disclosure Report  
05/09/2024
3:59 PM
RxSight (Filer)
Form 424B5
05/08/2024
3:41 PM
RxSight (Filer)
Form 424B5
05/03/2024
10:48 AM
Kurtz Ronald M MD (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:58 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:33 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2024
3:30 PM
RxSight (Filer)
Form DEF 14A
04/25/2024
3:31 PM
RxSight (Filer)
Form DEFA14A
04/25/2024
3:32 PM
RxSight (Filer)
Form ARS
04/01/2024
3:18 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:24 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:05 PM
RxSight (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:16 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:38 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
3:15 PM
RxSight (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:44 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
6:54 AM
LORD, ABBETT & CO. LLC (Filed by)
RxSight (Subject)
Form SC 13G
02/12/2024
5:02 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
5:19 AM
Artisan Partners Limited Partnership (Filed by)
RxSight (Subject)
Form SC 13G
02/09/2024
4:11 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
7:20 PM
Corley Jesse Anderson (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
4:18 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
4:55 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
5:01 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:47 PM
RxSight (Issuer)
Weinberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:47 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:49 PM
LINK WILLIAM J PHD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
4:10 PM
LINK WILLIAM J PHD (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
3:31 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
2:31 PM
RxSight (Subject)
Weinberg Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
4:36 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
4:27 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
6:48 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
6:50 PM
RxSight (Issuer)
Weinberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
3:32 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
2:10 PM
RxSight (Subject)
Weinberg Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/19/2024
3:01 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
2:17 PM
Maniar Shweta (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2024
4:28 PM
RxSight (Issuer)
Weinberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
4:29 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:37 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:09 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:10 PM
RxSight (Issuer)
Warner Robert Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:12 PM
RxSight (Issuer)
Weinberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
2:44 PM
RxSight (Subject)
Weinberg Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

01/08/2024
4:00 PM
Maniar Shweta (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:41 PM
RxSight (Subject)
Warner Robert Keith (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:34 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
2:57 PM
RxSight (Subject)
Weinberg Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
1:44 PM
Kurtz Ronald M MD (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
5:01 AM
RxSight (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
3:47 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
1:54 PM
Kurtz Ronald M MD (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:10 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RXST) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners